loading...| Preferred Name |
Oxandrolone |
|
| Synonyms |
|
|
| Definitions |
A synthetic, anabolic steroid hormone analog of testosterone. Similar to testosterone, oxandrolone binds to and activates specific nuclear receptors. This agent may be used for testosterone replacement therapy in hypogonadal men, in HIV-wasting syndrome, and in other conditions in order to increase nitrogen retention and fat-free muscle mass. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C29306 |
|
| Accepted_Therapeutic_Use_For |
Bone pain; Duchenne's and Becker muscular dystrophy; HIV-associated muscle weakness; Wasting syndrome, treatment including HIV-related |
|
| ALT_DEFINITION |
A drug used to help patients gain weight after injury, chronic infection, or severe illness. It belongs to the family of drugs called anabolic steroids. |
|
| CAS_Registry |
53-39-4 |
|
| CHEBI_ID |
CHEBI:7820 |
|
| Chemical_Formula |
C19H30O3 |
|
| code |
C29306 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic, anabolic steroid hormone analog of testosterone. Similar to testosterone, oxandrolone binds to and activates specific nuclear receptors. This agent may be used for testosterone replacement therapy in hypogonadal men, in HIV-wasting syndrome, and in other conditions in order to increase nitrogen retention and fat-free muscle mass. (NCI04) |
|
| FDA_UNII_Code |
7H6TM3CT4L |
|
| in_subset | ||
| label |
Oxandrolone |
|
| Legacy Concept Name |
Oxandrolone |
|
| NCI_Drug_Dictionary_ID |
331866 |
|
| NSC Number |
67068 |
|
| PDQ_Closed_Trial_Search_ID |
331866 |
|
| PDQ_Open_Trial_Search_ID |
331866 |
|
| Preferred_Name |
Oxandrolone |
|
| prefixIRI |
NCIT:C29306 |
|
| prefLabel |
Oxandrolone |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0029995 |
|
| subClassOf |